Product Information
ARIPIPRAZOLE 2 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1146 per EA under NDC 82009008805. Its NADAC has been published 155 times since Oct 18, 2023.
FDA first approved this application on Sep 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009008805
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA206174FDA Approved
9/12/2016
TE Code
AB
On Market Since
7/19/2023
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 2 MG TABLET has been published 155 times since Oct 18, 2023, and over the history we have for it it has declined 11.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1146 per EA |
|---|---|
| All-time high | $0.1678 (Mar 13, 2024) |
| All-time low | $0.1014 (Nov 20, 2024) |
| 52-week high | $0.1246 |
| 52-week low | $0.1026 |
| Median price | $0.1227 |
| Average price | $0.1211 |
| Largest weekly change | +33.3% (Aug 21, 2024) |
| Weeks tracked | 155 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quallent Pharmaceuticals Health LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 2 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1146 per EA (NDC 82009008805), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 2 MG TABLET has declined 11.3%. It has been tracked across 155 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 2 MG TABLET?
Since Oct 18, 2023, the NADAC for ARIPIPRAZOLE 2 MG TABLET has ranged from a low of $0.1014 (Nov 20, 2024) to a high of $0.1678 (Mar 13, 2024), with a median of $0.1227 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 2 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 2 MG TABLET?
ARIPIPRAZOLE 2 MG TABLET (NDC 82009008805) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.